Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome

被引：0
|
作者：
Ignatova, G. [1 ]
Blinova, E. [1 ]
机构：
[1] South Ural State Med Univ, Therapy, Chelyabinsk, Russia
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3322
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease
    Wedzicha, Jadwiga A.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (1-2): : 9 - 10
  • [2] Roflumilast: A Phosphodiesterase-4 Inhibitor for the Treatment of Severe Chronic Obstructive Pulmonary Disease
    Pinner, Nathan A.
    Hamilton, Leslie A.
    Hughes, Anthony
    CLINICAL THERAPEUTICS, 2012, 34 (01) : 56 - 66
  • [3] Experience of application the selective phosphodiesterase-4 inhibitor roflumilast in the patient with COPD and the metabolic syndrome
    Blinova, Elena
    Ignatova, Galina
    Belsner, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [4] Roflumilast: A new phosphodiesterase 4 inhibitor for chronic obstructive pulmonary disease
    Baker, Erica L.
    Baker, William L.
    FORMULARY, 2010, 45 (01) : 6 - 13
  • [5] Cilomilast: Orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease
    Martina, Shaunta' D.
    Ismail, Maha S.
    Vesta, Kimi S.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) : 1822 - 1828
  • [6] Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
    Jian Luo
    Ke Wang
    Dan Liu
    Bin-Miao Liang
    Chun-Tao Liu
    Respiratory Research, 17
  • [7] Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
    Rabe, Klaus F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (01) : 53 - 67
  • [8] Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
    Luo, Jian
    Wang, Ke
    Liu, Dan
    Liang, Bin-Miao
    Liu, Chun-Tao
    RESPIRATORY RESEARCH, 2016, 17
  • [9] Treatment of Chronic Obstructive Pulmonary Disease with Roflumilast, a New Phosphodiesterase 4 Inhibitor
    Gross, Nicholas J.
    Giembycz, Mark A.
    Rennard, Stephen I.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (02) : 141 - 153
  • [10] The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
    Hatzelmann, Armin
    Morcillo, Esteban J.
    Lungarella, Giuseppe
    Adnot, Serge
    Sanjar, Shahin
    Beume, Rolf
    Schudt, Christian
    Tenor, Hermann
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (04) : 235 - 256
12345